Skip to main content

Featured

Canada's Rent Slide Is Finally Stalling — What It Means If You Rent or Rent Out

  Published August 13, 2026 For nearly two years, "Canadian rents are falling" has been one of the safest headlines in personal finance. The August 2026 National Rent Report from Rentals.ca and Urbanation, released last week, suggests that streak may finally be running out of road — and the shift matters whether you're the one paying rent or the one collecting it. The Numbers National avg. asking rent (July) $2,037 Year-over-year change -4.0% (22nd straight monthly decline) Month-over-month change +0.2% (4th straight monthly rise) Toronto, month-over-month +1.6% to $2,577 Falling, But Not as Fast Rent is still dropping on a year-over-year basis nationally — that's now been true for 22 straight months. But the pace of the decline has been easing since it bottomed out in March, and July marked the smallest annual drop since February. On a month-to-month basis, rent has now risen for four months running, which typically happens every summer as the market hits its season...
Post a Comment
Read more

article

Labels

Australia Slams Trump’s Drug Tariffs as Blow to Fair Trade

                                        Australian health minister Mark Butler 

Australia has sharply criticized U.S. President Donald Trump’s decision to impose a 100% tariff on imported branded pharmaceuticals, calling the move “unfair and unjustified.”

Health Minister Mark Butler said the tariffs risk harming both Australian exporters and American consumers, noting that Australia already imports far more pharmaceutical products from the United States than it exports. “It is not in the American consumers’ interest to impose a higher price on the exports from Australia to America, particularly given the degree to which their exporters to Australia benefit from free trade as well,” Butler said.

The new tariffs, set to take effect October 1, will apply unless pharmaceutical companies are actively building manufacturing plants in the U.S. The policy has rattled Australia’s healthcare sector, with shares in major biotech firms like CSL falling in response.

Canberra has vowed to continue defending its Pharmaceutical Benefits Scheme (PBS), which caps medicine prices domestically, despite pressure from U.S. pharmaceutical interests. Trade officials are in talks with Washington to clarify the scope of the tariffs and their potential impact on Australia’s $2 billion pharmaceutical export industry.

The dispute adds to growing trade tensions as Trump expands his protectionist agenda, with tariffs now spanning industries from heavy trucks to kitchen cabinets.


Labels:

Comments

Post a Comment